Cellebrite Non Current Liabilities Total vs Total Assets Analysis

CLBT Stock  USD 18.56  0.06  0.32%   
Cellebrite financial indicator trend analysis is way more than just evaluating Cellebrite DI prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cellebrite DI is a good investment. Please check the relationship between Cellebrite Non Current Liabilities Total and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Non Current Liabilities Total vs Total Assets

Non Current Liabilities Total vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cellebrite DI Non Current Liabilities Total account and Total Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cellebrite's Non Current Liabilities Total and Total Assets is -0.1. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of Cellebrite DI, assuming nothing else is changed. The correlation between historical values of Cellebrite's Non Current Liabilities Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Cellebrite DI are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Current Liabilities Total i.e., Cellebrite's Non Current Liabilities Total and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.1
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Current Liabilities Total

Total Assets

Total assets refers to the total amount of Cellebrite assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cellebrite DI books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Cellebrite's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cellebrite DI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
At this time, Cellebrite's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 4.7 B in 2025, whereas Tax Provision is likely to drop slightly above 4 M in 2025.
 2022 2023 2024 2025 (projected)
Depreciation And Amortization9.2M10.0M10.6M8.6M
Interest Income1.6M8.9M10.2M18.5M

Cellebrite fundamental ratios Correlations

0.840.960.670.61-0.210.810.97-0.85-0.430.760.90.910.84-0.690.930.880.270.58-0.10.840.90.730.75-0.260.96
0.840.940.40.85-0.570.770.91-0.85-0.190.590.890.90.67-0.310.640.98-0.130.120.150.860.950.50.88-0.520.79
0.960.940.530.77-0.410.881.0-0.87-0.260.680.930.980.83-0.540.790.970.150.330.070.930.980.610.88-0.40.92
0.670.40.530.120.230.450.54-0.55-0.830.930.440.460.36-0.680.750.470.440.76-0.750.410.420.970.210.110.53
0.610.850.770.12-0.880.60.73-0.71-0.030.420.740.760.53-0.120.360.79-0.03-0.180.370.740.770.290.84-0.840.62
-0.21-0.57-0.410.23-0.88-0.17-0.350.45-0.1-0.12-0.47-0.38-0.18-0.19-0.01-0.440.270.46-0.51-0.35-0.410.02-0.590.96-0.27
0.810.770.880.450.6-0.170.9-0.60.030.490.670.950.75-0.410.570.890.340.230.030.980.90.430.76-0.10.73
0.970.911.00.540.73-0.350.9-0.85-0.240.660.920.980.87-0.580.80.950.210.360.070.940.980.60.87-0.350.93
-0.85-0.85-0.87-0.55-0.710.45-0.6-0.850.5-0.75-0.96-0.78-0.790.69-0.77-0.820.02-0.26-0.1-0.7-0.84-0.69-0.860.56-0.85
-0.43-0.19-0.26-0.83-0.03-0.10.03-0.240.5-0.84-0.36-0.1-0.160.64-0.65-0.15-0.23-0.690.660.01-0.11-0.88-0.020.11-0.37
0.760.590.680.930.42-0.120.490.66-0.75-0.840.640.580.47-0.690.790.60.380.63-0.550.510.560.990.43-0.260.66
0.90.890.930.440.74-0.470.670.92-0.96-0.360.640.860.87-0.640.80.86-0.020.280.220.770.910.580.9-0.540.94
0.910.90.980.460.76-0.380.950.98-0.78-0.10.580.860.84-0.480.690.960.230.250.130.990.980.510.89-0.340.87
0.840.670.830.360.53-0.180.750.87-0.79-0.160.470.870.84-0.770.740.720.280.320.30.790.830.430.84-0.280.91
-0.69-0.31-0.54-0.68-0.12-0.19-0.41-0.580.690.64-0.69-0.64-0.48-0.77-0.8-0.37-0.46-0.640.18-0.4-0.47-0.72-0.450.03-0.73
0.930.640.790.750.36-0.010.570.8-0.77-0.650.790.80.690.74-0.80.650.310.8-0.270.580.690.80.52-0.130.91
0.880.980.970.470.79-0.440.890.95-0.82-0.150.60.860.960.72-0.370.650.010.170.090.940.980.530.88-0.390.8
0.27-0.130.150.44-0.030.270.340.210.02-0.230.38-0.020.230.28-0.460.310.010.51-0.390.260.050.38-0.040.170.26
0.580.120.330.76-0.180.460.230.36-0.26-0.690.630.280.250.32-0.640.80.170.51-0.660.150.190.7-0.080.340.52
-0.10.150.07-0.750.37-0.510.030.07-0.10.66-0.550.220.130.30.18-0.270.09-0.39-0.660.140.19-0.630.46-0.460.09
0.840.860.930.410.74-0.350.980.94-0.70.010.510.770.990.79-0.40.580.940.260.150.140.950.430.86-0.290.78
0.90.950.980.420.77-0.410.90.98-0.84-0.110.560.910.980.83-0.470.690.980.050.190.190.950.490.92-0.380.87
0.730.50.610.970.290.020.430.6-0.69-0.880.990.580.510.43-0.720.80.530.380.7-0.630.430.490.33-0.130.61
0.750.880.880.210.84-0.590.760.87-0.86-0.020.430.90.890.84-0.450.520.88-0.04-0.080.460.860.920.33-0.60.79
-0.26-0.52-0.40.11-0.840.96-0.1-0.350.560.11-0.26-0.54-0.34-0.280.03-0.13-0.390.170.34-0.46-0.29-0.38-0.13-0.6-0.35
0.960.790.920.530.62-0.270.730.93-0.85-0.370.660.940.870.91-0.730.910.80.260.520.090.780.870.610.79-0.35
Click cells to compare fundamentals

Cellebrite Account Relationship Matchups

Cellebrite fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets364.4M339.8M403.3M532.9M690.6M478.7M
Other Current Liab41.9M45.1M42.0M43.2M49.6M43.2M
Total Current Liabilities159.4M186.6M207.8M253.8M295.5M220.4M
Total Stockholder Equity63.8M(73.3M)73.9M34.2M336.0M352.8M
Property Plant And Equipment Net16.1M16.8M32.9M30.2M27.6M25.4M
Current Deferred Revenue106.1M123.0M152.7M196.6M217.0M158.6M
Net Debt(128.7M)(146.0M)(72.3M)(175.4M)(180.7M)(189.7M)
Retained Earnings28.3M78.4M199.2M118.1M(164.9M)(156.6M)
Accounts Payable4.7M9.5M4.6M8.3M74.4M78.1M
Cash128.7M146.0M87.6M189.5M191.7M150.3M
Non Current Assets Total40.1M66.6M107.4M123.9M123.0M87.9M
Non Currrent Assets Other565K2.0M1.7M12.9M7.7M4.6M
Other Assets7.9M11.8M14.2M(13.1M)(11.8M)(11.2M)
Cash And Short Term Investments237.6M181.6M183.6M302.9M447.2M284.8M
Net Receivables66.3M67.5M78.8M77.3M82.4M76.3M
Common Stock Shares Outstanding123.7M161.5M195.4M190.2M209.5M195.7M
Short Term Investments108.9M35.6M96.0M113.4M255.6M134.4M
Liabilities And Stockholders Equity364.4M339.8M403.3M532.9M690.6M478.7M
Non Current Liabilities Total141.2M226.6M121.7M244.8M59.0M56.1M
Inventory4.8M6.5M10.2M9.9M8.9M8.1M
Other Current Assets15.6M16.8M23.4M32.0M29.1M21.7M
Other Stockholder Equity(67.1M)(153.2M)(125.7M)(85.0M)498.8M523.7M
Total Liab300.6M413.1M329.4M498.7M354.5M388.3M
Net Invested Capital63.8M(73.3M)73.9M34.2M30.8M25.2M
Property Plant And Equipment Gross32.8M38.2M32.9M63.4M72.9M42.8M
Total Current Assets324.3M273.2M295.9M422.1M567.6M393.2M
Accumulated Other Comprehensive Income1.3M1.4M331K1.1M2.1M1.3M
Non Current Liabilities Other6.2M133.3M49.1M134.5M154.6M162.4M
Net Working Capital164.9M86.6M88.2M168.3M151.4M107.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.